Form 4: Encompass Health Corp: CEO Mark Tarr Acquires 12,152 Shares of Common Stock

Encompass Health Corp's CEO, Mark J. Tarr, acquired 12,152 shares of common stock on February 20, 2025, as part of an annual restricted stock award.

Summary

• Mark J. Tarr, the President & CEO of Encompass Health Corp, acquired 12,152 shares of Encompass Health Common Stock on February 20, 2025.
• The acquisition was an annual award of restricted stock granted under the Corporation's 2016 Omnibus Performance Incentive Plan.
• Following the transaction, Tarr directly owns 534,641 shares of Encompass Health Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by the CEO as part of a compensation plan. It doesn't inherently indicate positive or negative sentiment, but rather a routine business practice.

Positives

• The CEO's acquisition of shares may signal confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates the CEO's alignment with the company's success.

Key Dates

Keywords

Encompass Health Corp, Mark J Tarr, EHC, restricted stock, Form 4, beneficial ownership, insider trading